I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 10 studies | 31% ± 10% | |
| glutamatergic neuron | 7 studies | 42% ± 23% | |
| GABAergic neuron | 3 studies | 44% ± 9% | |
| astrocyte | 3 studies | 38% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 10 studies | 31% ± 10% | |
| glutamatergic neuron | 7 studies | 42% ± 23% | |
| GABAergic neuron | 3 studies | 44% ± 9% | |
| astrocyte | 3 studies | 38% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 35% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 4006.81 | 245 / 245 | 100% | 32.64 | 502 / 502 |
| breast | 100% | 1048.47 | 459 / 459 | 96% | 17.85 | 1072 / 1118 |
| brain | 100% | 2188.88 | 2633 / 2642 | 92% | 6.36 | 649 / 705 |
| kidney | 100% | 899.45 | 89 / 89 | 90% | 8.89 | 809 / 901 |
| lung | 100% | 923.13 | 577 / 578 | 81% | 4.90 | 931 / 1155 |
| bladder | 100% | 1071.86 | 21 / 21 | 72% | 4.42 | 361 / 504 |
| stomach | 93% | 440.27 | 333 / 359 | 77% | 4.22 | 220 / 286 |
| thymus | 99% | 567.44 | 647 / 653 | 66% | 2.26 | 402 / 605 |
| intestine | 92% | 464.67 | 885 / 966 | 67% | 3.20 | 353 / 527 |
| pancreas | 64% | 206.33 | 209 / 328 | 89% | 5.31 | 159 / 178 |
| adrenal gland | 98% | 524.00 | 254 / 258 | 52% | 3.73 | 120 / 230 |
| esophagus | 60% | 208.58 | 871 / 1445 | 79% | 5.43 | 145 / 183 |
| uterus | 75% | 633.96 | 127 / 170 | 62% | 3.40 | 285 / 459 |
| liver | 89% | 381.35 | 202 / 226 | 39% | 1.80 | 157 / 406 |
| skin | 84% | 428.29 | 1514 / 1809 | 43% | 2.59 | 202 / 472 |
| spleen | 100% | 821.58 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.29 | 1 / 1 |
| adipose | 100% | 1045.99 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 7.22 | 27 / 29 |
| ovary | 27% | 95.96 | 48 / 180 | 62% | 2.44 | 266 / 430 |
| blood vessel | 87% | 444.41 | 1163 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 4.08 | 36 / 45 |
| peripheral blood | 69% | 337.71 | 640 / 929 | 0% | 0 | 0 / 0 |
| heart | 58% | 196.78 | 497 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 28% | 0.87 | 22 / 80 |
| muscle | 11% | 26.54 | 86 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0005634 | Cellular component | nucleus |
| GO_0035064 | Molecular function | methylated histone binding |
| GO_0003714 | Molecular function | transcription corepressor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CDYL2 |
| Protein name | Chromodomain Y like 2 Chromodomain Y-like protein 2 (CDY-like 2) |
| Synonyms | |
| Description | |
| Accessions | Q8N8U2 ENST00000570137.7 ENST00000563890.5 ENST00000562812.5 ENST00000566173.3 A0A0B4J291 |
